Newborn Screening for Pompe Disease in Illinois: Experience with 684,290 Infants

Statewide newborn screening for Pompe disease began in Illinois in 2015. As of 30 September 2019, a total of 684,290 infants had been screened and 395 infants (0.06%) were screen positive. A total of 29 cases of Pompe disease were identified (3 infantile, 26 late-onset). While many of the remainder...

Descripción completa

Detalles Bibliográficos
Autores principales: Burton, Barbara K., Charrow, Joel, Hoganson, George E., Fleischer, Julie, Grange, Dorothy K., Braddock, Stephen R., Hitchins, Lauren, Hickey, Rachel, Christensen, Katherine M., Groepper, Daniel, Shryock, Heather, Smith, Pamela, Shao, Rong, Basheeruddin, Khaja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422983/
https://www.ncbi.nlm.nih.gov/pubmed/33073003
http://dx.doi.org/10.3390/ijns6010004
Descripción
Sumario:Statewide newborn screening for Pompe disease began in Illinois in 2015. As of 30 September 2019, a total of 684,290 infants had been screened and 395 infants (0.06%) were screen positive. A total of 29 cases of Pompe disease were identified (3 infantile, 26 late-onset). While many of the remainder were found to have normal alpha-glucosidase activity on the follow-up testing (234 of 395), other findings included 62 carriers, 39 infants with pseudodeficiency, and eight infants who could not be given a definitive diagnosis due to inconclusive follow-up testing.

Ejemplares similares